Analyzing CT images to assess metabolic complications in adrenal cancer patients
Assessment of Metabolic Complications in Patients With Adrenal Tumors Through Radiological Images
This study looks at CT scans of patients with adrenal tumors to see if there are any metabolic problems related to their condition.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 1000 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | IRCCS Azienda Ospedaliero-Universitaria di Bologna Academic / other |
| Locations | 1 site (Bologna) |
| Trial ID | NCT06801340 on ClinicalTrials.gov |
What this trial studies
This observational study focuses on analyzing existing CT images of patients with adrenal tumors to assess metabolic complications associated with the condition. Participating centers will identify eligible patients who have undergone adrenectomy or have benign adrenal tumors, and will send pseudonymized DICOM format images to a central coordinating center for radiomics analysis. The study ensures patient anonymity and data security throughout the process, with images accessible only to authorized personnel. The findings aim to enhance understanding of metabolic issues linked to adrenal tumors without impacting patient care.
Who should consider this trial
Good fit: Ideal candidates include adults aged 18 and older with adrenal tumors who have undergone surgery or have stable benign tumors confirmed by imaging.
Not a fit: Patients without adrenal tumors or those who do not have available CT images in DICOM format will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could provide insights into metabolic complications in adrenal cancer patients, potentially leading to improved management strategies.
How similar studies have performed: While similar radiomics approaches have been explored in other cancer types, this specific application to adrenal tumors is relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age ≥18 years * Patients with adrenal tumor who underwent adrenectomy surgery from 1-1-2000 to 30-5-2023, performed according to clinical necessity and indications of international guidelines,with availability of histologic diagnosis or adrenal tumor that did not undergo adrenectomy surgery with diagnosis of benignity confirmed by radiologic stability at 6-12 months after first finding(as indicated in guidelines) * Availability of radiological images in DICOM format of abdominal CT scan in which the adrenal tumor is first described, obtained on the date of first evaluation at the participating center (necessarily before surgery for patients undergoing adrenectomy) * Signature of informed consent Exclusion Criteria: * none
Where this trial is running
Bologna
- IRCCS Azienda Ospedaliero-Universitaria di Bologna — Bologna, Italy (Recruiting)
Study contacts
- Principal investigator: Guido Di Dalmazi, MD — IRCCS Azienda Ospedaliero-Universitaria di Bologna
- Study coordinator: Guido Di Dalmazi, MD
- Email: guido.didalmazi@unibo.it
- Phone: +390512143009
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.